-+ 0.00%
-+ 0.00%
-+ 0.00%

Rani Therapeutics joins H.C. Wainwright BioConnect investor conference at Nasdaq

PUBT·05/12/2026 20:07:37
Listen to the news
Rani Therapeutics joins H.C. Wainwright BioConnect investor conference at Nasdaq
  • Rani Therapeutics to participate in H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ on May 19, 2026.
  • CEO Talat Imran, CFO Svai Sanford scheduled for fireside chat at 10:00 a.m. ET.
  • Management also set for one-on-one meetings during conference in New York.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rani Therapeutics Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605121605PRIMZONEFULLFEED9718628) on May 12, 2026, and is solely responsible for the information contained therein.